Chemomab Therapeutics Ltd. financial statements
Chemomab Therapeutics Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 8.99M | 20-F |
| Cash and equivalents | USD 7.56M | 20-F |
Chemomab Therapeutics Ltd. financials on 6ix · Chemomab Therapeutics Ltd. on 6ix